Apogee Therapeutics, Inc. (APGE)
68.39
-0.54
(-0.78%)
USD |
NASDAQ |
Feb 20, 16:00
68.37
-0.02
(-0.03%)
After-Hours: 20:00
Apogee Therapeutics EPS Diluted (Quarterly) : -1.106 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| Ventyx Biosciences, Inc. | -0.3202 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Cogent Biosciences, Inc. | -0.6934 |
| Dyne Therapeutics, Inc. | -0.7619 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -65.02M |
| Total Expenses (Quarterly) | 65.02M |
| Enterprise Value | 4.155B |
| Earnings Yield | -6.31% |
| Normalized Earnings Yield | -6.315 |